Oil and fat industry biotech

verified 6 Jul 2026 valid until confidence MEDIUM 16 sources
fda efsa

01Overview and value chain

Markers: [EC: EU food enzyme authorization (Regulation (EC) 1332/2008) | OECD: Food systems | Regulator: FDA (USA), EFSA (EU)]

Oil and fat industry biotech applies enzymes to established edible-oil and specialty-fat processing steps — interesterification, degumming, fat splitting — replacing chemical catalysts with biological ones to cut yield loss, energy use or unwanted byproducts. AAK, a global specialty vegetable fats and oils leader, launched ILLEXAO EN 10 in mid-2026, a new cocoa butter equivalent for enrobed chocolate applications that helps manufacturers manage cocoa price volatility while improving formulation flexibility. Novonesis released Quara Supreme, a thermostable enzyme designed to reduce yield losses in water degumming by up to 2% — a traditionally major source of oil loss in vegetable-oil processing — and separately partnered with Thyssenkrupp Uhde to launch an enzymatic fat-splitting process aimed at cutting energy consumption and improving production flexibility and efficiency in fatty-acid production. Bunge holds patents on both a batch process for enzymatic lipid modification and a plant-based intramuscular fat substitute stabilized with the enzyme transglutaminase, while GEA has introduced an enzymatically enhanced degumming solution, GEA eTOP Degumming, extending the enzymatic-replacement trend into processing equipment itself.

Key directions of oil and fat industry biotech:

  1. Enzymatic degumming (Enzymatic Degumming): replacing or enhancing chemical degumming of crude vegetable oil with enzymes to recover additional yield and reduce processing losses.
  2. Enzymatic fat-splitting for fatty-acid production (Enzymatic Fat-Splitting for Fatty-Acid Production): biological catalysis replacing high-temperature/high-pressure chemical fat splitting to cut energy use.
  3. Specialty fat/cocoa butter equivalents (Specialty Fat/Cocoa Butter Equivalents): engineered vegetable fat blends substituting for volatile or constrained commodity fats like cocoa butter.
  4. Enzyme-stabilized plant-based fat substitutes (Enzyme-Stabilized Plant-Based Fat Substitutes): transglutaminase and similar enzymes stabilizing plant-oil-in-water emulsions as intramuscular fat replacements in blended meat products.

Sectoral value chain

Value chain levels

LevelDescriptionKey inputs/outputs
Crude Oil/Fat Sourcingprocuring crude vegetable oil or animal/plant fat feedstockIn: crude oil, fat feedstock. Out: processing feedstock.
Enzymatic Processingapplying enzymes to degum, split or interesterify the feedstockIn: feedstock, enzyme. Out: processed oil/fat fraction.
Yield/Quality Recoveryrecovering additional yield or quality versus chemical-only processingIn: processed fraction. Out: recovered yield/quality metric.
Specialty Fat Formulationformulating the processed oil/fat into a specialty product (cocoa butter equivalent, fat substitute)In: processed fraction. Out: formulated specialty fat.
Food-Enzyme Authorizationclearing FDA or EU Regulation (EC) 1332/2008 review for the enzyme usedIn: safety dossier. Out: market authorization.
Food Manufacturer Saleselling the specialty fat/oil product to food manufacturersIn: authorized product. Out: revenue.

Cross-cutting technologies of the sector:

  • Thermostable degumming enzymes (Thermostable Degumming Enzymes): enzyme variants engineered to remain active at the temperatures used in industrial oil degumming.
  • Enzymatic fat-splitting catalysis (Enzymatic Fat-Splitting Catalysis): biological catalysts replacing high-temperature/pressure chemical fat splitting in fatty-acid production.
  • Enzyme-stabilized emulsion formulation (Enzyme-Stabilized Emulsion Formulation): enzymes such as transglutaminase stabilizing plant-oil-in-water emulsions for use as fat substitutes.

02US

The US hosts a major agribusiness holding enzymatic lipid-modification and plant-based fat-substitute patents.

enzymatic lipid modification patents, plant-based intramuscular fat substitutes, batch enzymatic processing

  • Bunge: holds a patent for a batch process enabling enzymatic modification of lipids, and a separate patent for a plant-based intramuscular fat substitute combining plant proteins with plant oils in an oil-in-water emulsion stabilized by the enzyme transglutaminase.

03CN

Public information on a dedicated Chinese oil-and-fat-industry biotech originator was not confirmed with company-specific detail in this pass; the section stays at the policy level.

no confirmed company-specific detail this pass, adjacent bio-based fuel/polymer research activity

  • No confirmed company-specific detail this pass: the Chinese candidates investigated in this pass returned market-research reports on castor-oil-based biopolymers and bio-jet fuel equipment, plus unrelated investment news, rather than a source confirming a specific oil/fat-processing enzyme originator.
  • Adjacent bio-based research activity: academic and industrial activity around castor-oil biopolymers and biofuel production is active in the region, adjacent to but distinct from enzymatic edible-oil/fat processing specifically.

04EU

Sweden, Denmark and Germany anchor the region’s activity, spanning a specialty-fats leader, the sector’s dominant enzyme supplier and an equipment maker extending enzymatic processing into hardware.

cocoa butter equivalent launch, degumming yield-recovery enzyme, enzyme-enhanced processing equipment

  • AAK: launched ILLEXAO EN 10 in mid-2026, a new cocoa butter equivalent for enrobed chocolate applications helping manufacturers manage cocoa price volatility while improving formulation flexibility.
  • Novonesis: released Quara Supreme, a thermostable enzyme reducing yield losses in vegetable-oil water degumming by up to 2%, and partnered with Thyssenkrupp Uhde to launch an enzymatic fat-splitting process cutting energy consumption in fatty-acid production.
  • GEA Group: introduced GEA eTOP Degumming, an enzymatically enhanced degumming solution extending the enzymatic-replacement trend into processing equipment itself.

05Leading companies and research institutes

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
AAK🇸🇪 SwedenILLEXAO EN 10 cocoa butter equivalentspecialty vegetable fat formulation (2026 launch)Commercial
Bunge🇺🇸 USAEnzymatic lipid modification, plant-based fat substitutebatch enzymatic process; transglutaminase-stabilized emulsionCommercial
Novonesis🇩🇰 DenmarkQuara Supreme, enzymatic fat-splitting2% degumming yield recovery; Thyssenkrupp Uhde partnershipCommercial
GEA Group🇩🇪 GermanyGEA eTOP Degummingenzymatically enhanced degumming equipmentOperating
Gepzymes🇮🇳 IndiaPrecision enzyme solutionsindustrial enzyme platform for processing efficiencyCommercial

06Tech stack and innovations

The stack replaces chemical catalysis with enzymatic catalysis at specific, well-defined oil/fat processing steps.

  1. Thermostable enzyme degumming (Thermostable Enzyme Degumming):
    • a thermostable enzyme variant survives industrial degumming temperatures to recover yield that would otherwise be lost.
    • case: Novonesis’s Quara Supreme recovers up to 2% additional yield in vegetable-oil water degumming.
  2. Enzymatic fat-splitting for energy reduction (Enzymatic Fat-Splitting for Energy Reduction):
    • biological catalysis replaces the high-temperature/pressure chemical process traditionally used to split fats into fatty acids.
    • case: the Novonesis/Thyssenkrupp Uhde enzymatic fat-splitting process is explicitly aimed at cutting energy consumption in fatty-acid production.
  3. Transglutaminase-stabilized fat-substitute emulsions (Transglutaminase-Stabilized Fat-Substitute Emulsions):
    • the enzyme transglutaminase stabilizes a plant-oil-in-water emulsion to function as an intramuscular fat substitute.
    • case: Bunge’s patented plant-based fat substitute combines plant proteins and oils in exactly this enzyme-stabilized emulsion format.

07Value chains and production pipelines

Industrial pipeline of an enzymatically processed specialty fat (EU Reg. 1332/2008 authorization)

Stage 1: Crude oil/fat sourcing

Crude vegetable oil or animal/plant fat feedstock is procured for processing.

Stage 2: Enzymatic processing

Enzymes are applied to degum, split or interesterify the feedstock in place of, or alongside, chemical catalysts.

Stage 3: Yield/quality recovery

The enzymatic step recovers additional yield or quality — e.g., up to 2% more oil in degumming — versus a chemical-only process.

Stage 4: Specialty fat formulation

The processed oil or fat is formulated into a specialty product such as a cocoa butter equivalent or an enzyme-stabilized fat substitute.

Stage 5: Food-enzyme authorization

The enzyme and resulting product clear FDA review or EU Regulation (EC) 1332/2008 authorization before sale.

Stage 6: Food manufacturer sale

The specialty fat or oil product is sold to food manufacturers managing commodity price volatility or formulation requirements.

SupplierPriceCertificatesRiskConfidence
Bungeon requestLowMEDIUM
GEA Groupon requestLowMEDIUM
Gepzymeson requestMediumLOW
AI Recommendation

AI note: oil-fat-industry-biotech (EN)

Key directions:

  1. Enzymatic degumming — enzymes replacing/enhancing chemical degumming to recover additional oil yield.
  2. Enzymatic fat-splitting for fatty-acid production — biological catalysis replacing high-temp/pressure chemical splitting.
  3. Specialty fat/cocoa butter equivalents — engineered vegetable fat blends substituting for volatile commodity fats.
  4. Enzyme-stabilized plant-based fat substitutes — transglutaminase stabilizing plant-oil emulsions as intramuscular fat replacements.

Regulatory:

  • EU: Regulation (EC) 1332/2008 governs food enzyme authorization for the enzymes used in these processes.
  • US: general FDA food-enzyme/ingredient review applies; no dedicated oil/fat-biotech-specific statute confirmed.

Companies not in table: Wilmar International was the original China candidate but returned only unrelated market-research reports (castor-oil biopolymers, bio-jet fuel equipment) rather than a source confirming its own oil/fat-biotech activity, so it was excluded per the strict re-verify rule; Biolaxi Enzymes (India) was considered as an alternate to Gepzymes but Gepzymes’ direct-site confirmation was stronger and more specifically enzyme-processing-focused for this pass.

Processing note: this article deliberately covers the TRADITIONAL edible-oil/fat industry’s enzymatic upgrade path (degumming, fat-splitting, interesterification of existing commodity oils) — distinct from the sibling biosynthetic-palm-fat article (precision-fermentation-grown novel palm-oil alternatives, already skipped as MECE against IND-028) and the cellular-fats-cultured-lipids article (true animal cell culture for cultivated fat). Zero company overlap across all three confirms the MECE boundary held even though “oil and fat” appears in all three titles.

Relevance: Novonesis’s two separate 2026 announcements in this vertical (Quara Supreme degumming enzyme, the Thyssenkrupp Uhde fat-splitting partnership) — on top of its cheese-culture and bakery-enzyme activity already documented in sibling articles — is the clearest evidence in this batch that a single diversified bioscience group can be a genuinely non-duplicative, load-bearing company across many distinct food-biotech verticals simultaneously.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.